ADVACAT Nickel-containing Stainless Steel Feedstock for MIM

Hazard statements (CLP)

H315, H317, H319, H335, H351, H372, H400, H410

Code

Statements

H315

Causes skin irritation

OSHA HCS Classification

Causes skin irritation, H315 Skin sensitisation (Category 1), H317 Causes serious eye irritation (Category 2A), H319 Specific target organ toxicity – single exposure, Respiratory system (Category 3), H335 Carcinogenicity (Category 2), H351 Specific target organ toxicity – repeated exposure, Inhalation (Category 1), H372 Acute aquatic toxicity (Category 1), H400 Chronic aquatic toxicity (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16. AMPCATSDS.02 1 of 14

Signal word

Danger

Hazard statements

H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H372 Causes damage to organs through prolonged or repeated exposure if inhaled. H410 Very toxic to aquatic life with long lasting effects.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 + P312 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/ physician if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do so. Continue rinsing. P308 + P313 If exposed or concerned: Get medical advice/ attention. P321 Specific treatment (see supplemental first aid instructions on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ attention. P363 Wash contaminated clothing before reuse. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam for extinction. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. AMPCATSDS.02 2 of 14

2.3 Other hazards

Labeling of special preparations (GHS): HEATING DURING PROCESSING OF PRODUCT MAY RESULT IN RELEASE OF THE DECOMPOSITION PRODUCT FORMALDEHYDE. MAY EMIT FORMALDEHYDE WHICH CAN CAUSE CANCER. EU Risk Phrases: The International Agency for Research on Cancer (IARC) Monograph Supplement 7 includes the following information on nickel: Three investigations that examined the possible cancer risk associated with exposure to nickel and nickel compounds in nickel alloy plants showed no significant increase in mortality from cancer. In one of these, excess mortality from lung cancer was noted in maintenance workers; however, it was unc1ear whether the risk was directly associated with nickel exposures. Workers at a gaseous diffusion plant who were exposed to high-purity metallic nickel powder did not exhibit any increase in mortality from respiratory-tract cancers. An incidence study at a hydrometallurgical nickel refining plant in Canada did not indicate an increased risk of cancer. Exposure was to metallic nickel and nickel concentrate dust. International Agency for Research on Cancer (IARC) Group 2B is defined as: Group 2B: The agent (mixture) is possibly carcinogenic to humans. The exposure circumstance entails exposures that are possibly carcinogenic to humans. This category is used for agents, mixtures and exposure circumstances for which there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals. It may also be used when there is inadequate evidence of carcinogenicity in humans but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, an agent, mixture or exposure circumstance for which there is inadequate evidence of carcinogenicity in humans but limited evidence of carcinogenicity in experimental animals together with supporting evidence from other relevant data may be placed in this group. International Agency for Research on Cancer (IARC) Group 3 is defined as: Group 3: The agent (mixture or exposure circumstance) is not classifiable as to its carcinogenicity to humans. This category is used most commonly for agents, mixtures and exposure circumstances for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents (mixtures) for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents, mixtures and exposure circumstances that do not fall into any other group are also placed in this category.

Potential health effects

Although there are no test data, there are no reported cases of any health problems from exposure to this product. As a normal precaution, excessive dusting or inhalation of fines should be avoided. Particle respirators should be worn if there is excessive dusting when handling the material. Thorough exhausting of fumes from hot material should be achieved to mitigate formaldehyde concentrations outside of OSHA limits which are governed by 29 CFR 1910.1048. If adequate ventilation cannot be achieved, organic vapor respirators with particulate prefilters should be utilized. See Section 8.2 for information on personal protective equipment (PPE). AMPCATSDS.02 3 of 14